FIELD: biotechnology.
SUBSTANCE: intraperitoneal administration of hyaluronidase is carried out in a dose of 1000 CU/kg of body weight. And simultaneously hydrolyzate of ribonucleic acid is administered intraperitoneally, consisting of mono-, di-, tri-, tetra-, penta- and hexanucleotides pH 7.2 in a dose of 1 µg/kg body weight once a day for 2 days.
EFFECT: increase in efficiency in increasing the pool of stem cells.
1 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF INTENSIFICATION OF STEM CELLS MOBILISATION | 2006 |
|
RU2330674C1 |
METHOD OF TREATING CONSEQUENCES OF HERPETIC MENINGOENCEPHALITIS WITH USE OF AUTOLOGOUS MESENCHYMAL STEM CELLS | 2011 |
|
RU2470649C1 |
METHOD FOR INCREASE OF STEM CELLS RESERVE IN ORGANISM | 2007 |
|
RU2347583C1 |
EXPERIMENTAL TOXIC CHRONIC HEPATITIS TREATMENT METHOD | 2009 |
|
RU2392000C1 |
METHOD OF INCREASING STEM CELLS MOBILIZATION | 2009 |
|
RU2442601C2 |
METHOD OF MYELOPOIESIS STIMULATION | 2008 |
|
RU2366452C1 |
ANABOLIC AGENT | 2008 |
|
RU2378007C1 |
METHOD FOR PREPARING CELL TRANSPLANTATION MATERIAL IN MYELOSUPPRESSION | 2008 |
|
RU2392947C1 |
AGENT FOR INCREASING RESERVED STEM CELL NUMBER IN ORGANISM | 2009 |
|
RU2405822C1 |
METHOD OF TREATING HEPATIC FAILURE | 2017 |
|
RU2655528C1 |
Authors
Dates
2015-09-20—Published
2014-07-29—Filed